Stock market tips of the week. (© DR)
The Paris Stock Exchange continues its momentum, supported by good economic figures. The CAC 40 hit, on June 3, a new high since autumn 2000 at 6,522.23 points. In this favorable environment, discover our advice on more than 30 actions.
The equity markets are still celebrating. IPOs are increasing and the CAC 40 has been sailing to levels more seen since 2000. Dividends reinvested, the Parisian index is even at an all-time high.
In this context, find the advice of the Revenue on 31 actions. We recommend twelve to buy, ten to sell and nine to keep.
The most significant news (Airbus, Safran, Believe, Vallourec, Société Générale …) are the subject of a specific development, accessible by clicking on the hypertext links.
Our advice on 31 AB Science actions
The exchanges have still not resumed on the action. But the order book indicates a “theoretical opening” towards 4 euros. AB Science requested the suspension of its listing after announcing the voluntary cessation – in consultation with the health authorities – of several advanced clinical studies (Covid-19, mastocytosis …) testing its Masitinib. The flagship product of biotech could indeed promote the development of ischemic heart disease, a pathology that increases the risk of suffering a myocardial infarction. Sell
The title still loses nearly 29% in three years. The French hotel industry champion launched a Spac, called AAC (Accor Acquisition
Read more on LeRevenu.com